COLLPLANT BIOTECHNOLOGIES LT (CLGN)

IL0004960188 - Common Stock

3.5  +0.06 (+1.74%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
15.64M
154.72%
300K
-98.08%
10.959M
3,553.00%
1.673M
-84.73%
13.26M
692.59%
20.239M
52.63%
EBITDA
YoY % growth
1.21M
124.49%
-15.72M
-1,399.17%
-5.544M
64.73%
N/AN/AN/A
EBIT
YoY % growth
440K
107.86%
-16.8M
-3,918.18%
-6.646M
60.44%
-17.388M
-161.64%
-6.498M
62.63%
-128.52K
98.02%
Operating Margin
2.81%-5,600.00%-60.64%-1,039.36%-49.01%-0.64%
EPS
YoY % growth
-0.01
98.73%
-1.53
-15,200.00%
-0.46
69.93%
-1.47
-219.30%
-0.40
72.57%
-0.03
93.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.28
-16.88%
-0.38
-2.00%
0.30
179.95%
-0.32
16.79%
-0.32
-12.73%
Revenue
Q2Q % growth
440.64K
47.37%
918K
836.73%
10.2M
3,996.39%
1.734M1.938M
339.81%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-4.581M
9.61%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.38 -0.29-0.09-30.72%
Q2 2024
Q2Q % growth
-0.37
-175.51%
-0.28-0.09-34.35%
Q1 2024
Q2Q % growth
-0.37
-12.12%
-0.36-0.01-3.64%
Q4 2023
Q2Q % growth
-0.24
36.84%
-0.07-0.17-236.13%
Q3 2023
Q2Q % growth
-0.38
5.00%
-0.13-0.25-186.58%
Q2 2023
Q2Q % growth
0.49
225.64%
0.020.473,102.61%
Q1 2023
Q2Q % growth
-0.33
8.33%
-0.30-0.03-11.56%
Q4 2022
Q2Q % growth
-0.38
-26.67%
-0.32-0.06-18.27%
Q3 2022
Q2Q % growth
-0.40
-37.93%
-0.32-0.08-26.50%
Q2 2022
Q2Q % growth
-0.39
-30.00%
-0.08-0.31-377.94%
Q1 2022
Q2Q % growth
-0.36
-140.91%
-0.14-0.22-152.10%
Q4 2021
Q2Q % growth
-0.30
28.57%
-0.300.00-1.42%
Q3 2021
Q2Q % growth
-0.29
-514.29%
-0.290.00-1.54%
Q2 2021
Q2Q % growth
-0.30
-50.00%
-0.10-0.20-194.12%
Q1 2021
Q2Q % growth
0.88
466.67%
0.520.3670.84%
Q4 2020
Q2Q % growth
-0.42
-68.00%
-0.31-0.11-37.25%
Q3 2020
Q2Q % growth
0.07
117.07%
0.94-0.87-92.54%
Q2 2020
Q2Q % growth
-0.20 -0.16-0.04-26.50%
Q1 2020
Q2Q % growth
-0.24 -0.23-0.01-2.30%
Q4 2019
Q2Q % growth
-0.25 -0.260.012.39%
Q3 2019
Q2Q % growth
-0.41 -0.32-0.09-29.79%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
4K
-100.00%
424.32K-424.32K-100.00%
Q2 2024
Q2Q % growth
249K
-97.55%
408K-159K-38.97%
Q1 2024
Q2Q % growth
98K
-77.37%
612K-514K-83.99%
Q4 2023
Q2Q % growth
299K
398.33%
8.735M-8.436M-96.58%
Q3 2023
Q2Q % growth
43K
-60.91%
3.566M-3.523M-98.79%
Q2 2023
Q2Q % growth
10.184M
14,448.57%
5.255M4.929M93.80%
Q1 2023
Q2Q % growth
433K
518.57%
245.82K187.18K76.15%
Q4 2022
Q2Q % growth
60K
-80.65%
51K9K17.65%
Q3 2022
Q2Q % growth
110K
-21.43%
110K%
Q2 2022
Q2Q % growth
70K
-89.86%
2.914M-2.844M-97.60%
Q1 2022
Q2Q % growth
70K
-99.52%
2.793M-2.723M-97.49%
Q4 2021
Q2Q % growth
310K
-44.64%
310K%
Q3 2021
Q2Q % growth
140K
-96.63%
125.46K14.54K11.59%
Q2 2021
Q2Q % growth
690K
-15.85%
3.167M-2.477M-78.21%
Q1 2021
Q2Q % growth
14.5M
2,277.05%
10.26M4.24M41.33%
Q4 2020
Q2Q % growth
560K
27.27%
290.19K269.81K92.98%
Q3 2020
Q2Q % growth
4.15M
510.29%
11.966M-7.816M-65.32%
Q2 2020
Q2Q % growth
820K
34.43%
1.57M-750K-47.77%
Q1 2020
Q2Q % growth
610K
3.39%
714K-104K-14.57%
Q4 2019
Q2Q % growth
440K 717.743K-277.743K-38.70%
Q3 2019
Q2Q % growth
680K 704.504K-24.504K-3.48%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS25.68% 25.68% -14.74% -14.74%
Revenue-46% -46% -2.85% -2.85%